These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 19526164

  • 1. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia. Risk factors and outcome in the eastern region of Saudi Arabia.
    Memon JI, Rehmani RS, Ahmed MU, Elgendy AM, Nizami IY.
    Saudi Med J; 2009 Jun; 30(6):803-8. PubMed ID: 19526164
    [Abstract] [Full Text] [Related]

  • 2. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
    Panhotra BR, Saxena AK, Al-Ghamdi AM.
    Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
    [Abstract] [Full Text] [Related]

  • 3. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, Xie X.
    Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
    [Abstract] [Full Text] [Related]

  • 4. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO.
    Clin Infect Dis; 2001 Apr 15; 32(8):1162-71. PubMed ID: 11283805
    [Abstract] [Full Text] [Related]

  • 8. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Wang SS, Lee NY, Hsueh PR, Huang WH, Tsui KC, Lee HC, Wu CJ, Chang CM, Huang CC, Huang CF, Ko WC.
    J Microbiol Immunol Infect; 2011 Aug 15; 44(4):282-8. PubMed ID: 21524962
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI, Chung DR, Ko KS, Peck KR, Song JH, Korean Network for Study of Infectious Diseases.
    Ann Hematol; 2012 Jan 15; 91(1):115-21. PubMed ID: 21556875
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
    Zaoutis TE, Goyal M, Chu JH, Coffin SE, Bell LM, Nachamkin I, McGowan KL, Bilker WB, Lautenbach E.
    Pediatrics; 2005 Apr 15; 115(4):942-9. PubMed ID: 15805368
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ, Roberts CH, Cooper SJ, Bellinghan G, Shetty N.
    J Hosp Infect; 2008 Feb 15; 68(2):108-15. PubMed ID: 18063198
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors.
    Ozgunes I, Erben N, Kiremitci A, Kartal ED, Durmaz G, Colak H, Usluer G, Colak E.
    Saudi Med J; 2006 May 15; 27(5):608-12. PubMed ID: 16680246
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli.
    Wu UI, Yang CS, Chen WC, Chen YC, Chang SC.
    J Microbiol Immunol Infect; 2010 Aug 15; 43(4):310-6. PubMed ID: 20688291
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.
    Ku NS, Kim YC, Kim MH, Song JE, Oh DH, Ahn JY, Kim SB, Kim HW, Jeong SJ, Han SH, Kim CO, Song YG, Kim JM, Choi JY.
    Arch Gerontol Geriatr; 2014 Aug 15; 58(1):105-9. PubMed ID: 23988261
    [Abstract] [Full Text] [Related]

  • 15. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
    Chen YH, Yao WZ, Wu R, Zhou QT, Liu ZY, Zhang XW.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov 15; 31(11):815-9. PubMed ID: 19080534
    [Abstract] [Full Text] [Related]

  • 16. Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.
    Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y.
    Antimicrob Agents Chemother; 2006 Apr 15; 50(4):1257-62. PubMed ID: 16569837
    [Abstract] [Full Text] [Related]

  • 17. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
    Kim SH, Kwon JC, Choi SM, Lee DG, Park SH, Choi JH, Yoo JH, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS.
    Ann Hematol; 2013 Apr 15; 92(4):533-41. PubMed ID: 23161391
    [Abstract] [Full Text] [Related]

  • 18. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
    Peña C, Gudiol C, Calatayud L, Tubau F, Domínguez MA, Pujol M, Ariza J, Gudiol F.
    J Hosp Infect; 2008 Feb 15; 68(2):116-22. PubMed ID: 18226420
    [Abstract] [Full Text] [Related]

  • 19. Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London.
    Skippen I, Shemko M, Turton J, Kaufmann ME, Palmer C, Shetty N.
    J Hosp Infect; 2006 Oct 15; 64(2):115-23. PubMed ID: 16859810
    [Abstract] [Full Text] [Related]

  • 20. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
    Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R, Arnan M, Marin M, Carratalà J, Gudiol F.
    J Antimicrob Chemother; 2010 Feb 15; 65(2):333-41. PubMed ID: 19959544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.